TotalMarketCap

Amgen

AMGNNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$220.275 B

$407.44 -1.36%

Close of 9 Oct 2026

As of 9 Oct 2026, Amgen (AMGN) has a market capitalization of $220.3B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$36.8B

#118 by revenue

Earnings

$7.71B

#61 by earnings

Shares outstanding

540,632,005

Latest filing cover page

P/E ratio

28.6

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →
  1. #1AmgenAMGN$220.3B
  2. #2Gilead SciencesGILD$182.4B
  3. #3ModernaMRNA$78.6B
  4. #4Argenx SeARGX$50.8B
  5. #5Revolution MedicinesRVMD$40.3B

What if Amgen were worth as much as…

Open the what-if tool →

Gold $29.1T

$53,755.34

Per share 132× higher

Bitcoin $1.66T

$3,071.55

Per share 7.54× higher

Nvidia $5.55T

$10,274.21

Per share 25.2× higher

Or at a round number

$500.0B$1.00T$2.00T$5.00T

Where these numbers come from

Share counts and financials for Amgen are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 10 Oct 2026. Read the methodology.